Assignee
ALTOR BIOSCIENCE LLC
US·35 granted patents·12 pending applications·221 citations·filing 2017–2025
Top patents by PatentIndex Score
47 records- 0199US11845783B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2021·Granted Dec 19, 2023·6 cites·5 claims
- 0299US11104716B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Aug 31, 2021·12 cites·17 claims
- 0399US11046747B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 29, 2021·18 cites·13 claims
- 0498US11992516B2Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodiesALTOR BIOSCIENCE LLC·Filed 2022·Granted May 28, 2024·3 cites·10 claims
- 0598US11925676B2Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complexALTOR BIOSCIENCE LLC·Filed 2023·Granted Mar 12, 2024·3 cites·23 claims
- 0698US11890323B2Method of treating cancer with composition comprising IL-15-based molecules and BCGALTOR BIOSCIENCE LLC·Filed 2022·Granted Feb 6, 2024·3 cites·6 claims
- 0798US11679144B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 20, 2023·6 cites·9 claims
- 0898US11673932B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 13, 2023·10 cites·13 claims
- 0998US11471511B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Granted Oct 18, 2022·13 cites·7 claims
- 1098US11173191B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 16, 2021·13 cites·8 claims
- 1198US10899821B2Method of treating neoplasia with a multimeric IL-15 soluble fusion moleculeALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 26, 2021·15 cites·21 claims
- 1298US10537615B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 21, 2020·23 cites·7 claims
- 1397US11612645B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2022·Granted Mar 28, 2023·6 cites·4 claims
- 1497US11571470B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2021·Granted Feb 7, 2023·6 cites·5 claims
- 1597US11498950B1Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 15, 2022·9 cites·7 claims
- 1697US11369679B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 28, 2022·10 cites·16 claims
- 1797US11318201B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2021·Granted May 3, 2022·13 cites·9 claims
- 1897US11129883B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2018·Granted Sep 28, 2021·16 cites·14 claims
- 1996US11975059B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted May 7, 2024·2 cites·14 claims
- 2096US11365231B2Interleukin 15 (IL-15) variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·10 cites·7 claims
- 2194US11872272B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 16, 2024·1 cites·7 claims
- 2294US2026061033A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 2393US12318432B2BCG and IL-15 based moleculesALTOR BIOSCIENCE LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 2493US12268732B2IL-15-based molecules with anti-CD20 antibody and methods of useALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·5 claims
- 2593US12268731B2Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)ALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·11 claims
- 2693US11161890B2IL-15-based fusions to IL-7 and IL-21ALTOR BIOSCIENCE LLC·Filed 2018·Granted Nov 2, 2021·5 cites·6 claims
- 2793US2024299498A1Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complexALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 2892US12097244B2Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibodyALTOR BIOSCIENCE LLC·Filed 2023·Granted Sep 24, 2024·0 cites·23 claims
- 2992US2026092097A1Multimeric il-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 3092US2025066442A1Fusion molecules and il-15 variantsALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3191US12371472B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2023·Granted Jul 29, 2025·0 cites·11 claims
- 3291US12233116B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2024·Granted Feb 25, 2025·0 cites·6 claims
- 3391US11168138B2Anti-PDL1, IL-15 and TGF-beta receptor combination moleculesALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 9, 2021·18 cites·17 claims
- 3489US12410224B2IL-15-based fusions to IL-7 and IL-21ALTOR BIOSCIENCE LLC·Filed 2023·Granted Sep 9, 2025·0 cites·8 claims
- 3589US12186372B2IL-15-based molecules and methods of treating a neoplasiaALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 7, 2025·0 cites·21 claims
- 3688US12168680B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2023·Granted Dec 17, 2024·0 cites·17 claims
- 3788US2024252609A1Il-15-based fusions to il-12 and il-18ALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3888US2024368237A1SENESCENCE TREATMENT with IL-15-BASED FUSIONS to IL-7 and IL-21ALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3987US2025262277A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 4087US2025262278A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 4179US11965007B2IL-15-based fusions to IL-7 and IL-21ALTOR BIOSCIENCE LLC·Filed 2021·Granted Apr 23, 2024·0 cites·8 claims
- 4275US2025152686A1Il-15-based fusions to il-12 and il-18ALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 4369US2020283498A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Application pending·0 cites
- 4462US10844107B2HIV VPR-specific T-cell receptorsALTOR BIOSCIENCE LLC·Filed 2017·Granted Nov 24, 2020·0 cites·6 claims
- 4554US2021008167A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 4650US2019328838A1Compositions comprising il-2 fusion proteins and methods for treating neoplasiaALTOR BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 4746US12325734B2Human immunodeficiency virus-specific T cell receptorsALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 10, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when ALTOR BIOSCIENCE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →